Salivary Cortisol and Cognitive Decline and Alzheimer Disease in Older Adults
-
By
-
Ted K. S. Ng
-
Todd Beck
-
Yashwanth Sudhini
-
Robert S. Wilson
-
Denis A. Evans
-
Kumar B. Rajan
-
July 15, 2026
Clinical Scorecard: Cortisol Levels in Saliva and Their Association with Cognitive Decline and Alzheimer’s Disease in Elderly Individuals
At a Glance
| Category | Detail |
|---|
| Condition | Alzheimer Disease (AD) |
| Key Mechanisms | HPA axis activity and cortisol levels influencing cognitive aging and neurodegeneration. |
| Target Population | Older adults, particularly racially diverse groups including Black and White individuals. |
| Care Setting | Community-based cohort studies. |
Key Highlights
- Salivary cortisol is a noninvasive and cost-effective biomarker for assessing HPA axis activity.
- Higher peripheral cortisol levels are associated with increased risk of Alzheimer's Disease and cognitive decline.
- The study evaluates diurnal cortisol patterns and their cognitive implications in a large cohort.
Guideline-Based Recommendations
Diagnosis
- Utilize diurnal salivary cortisol measures to assess HPA axis function in relation to cognitive outcomes.
Management
- Consider stress-related processes as modifiable risk factors for cognitive decline.
Monitoring & Follow-up
- Track longitudinal changes in salivary cortisol and cognitive function over time.
Risks
- Elevated cortisol levels may indicate increased risk for cognitive impairment and Alzheimer's Disease.
Patient & Prescribing Data
Older adults from racially diverse backgrounds.
Salivary cortisol may serve as a valuable marker for monitoring stress and cognitive health.
Clinical Best Practices
- Implement repeated intraday salivary sampling to capture diurnal variations in cortisol levels.
- Use area under the curve (AUC) measures for a comprehensive assessment of HPA axis activity.
Related Resources & Content
